Robotic ventral hernia repair: a safe and durable approach.

Autor: Sharbaugh ME; Department of General Surgery, Albany Medical Center, Albany, NY, USA. matthew.sharbaugh@gmail.com.; Department of General Surgery, Northern Light Health, 489 State Street, Bangor, ME, USA. matthew.sharbaugh@gmail.com., Patel PB; Department of General Surgery, Albany Medical Center, Albany, NY, USA., Zaman JA; Department of General Surgery, Albany Medical Center, Albany, NY, USA., Ata A; Department of General Surgery, Albany Medical Center, Albany, NY, USA., Feustel P; Department of General Surgery, Albany Medical Center, Albany, NY, USA., Singh K; Boston College, Boston, MA, USA., Singh TP; Department of General Surgery, Albany Medical Center, Albany, NY, USA.
Jazyk: angličtina
Zdroj: Hernia : the journal of hernias and abdominal wall surgery [Hernia] 2021 Apr; Vol. 25 (2), pp. 305-312. Date of Electronic Publication: 2019 Nov 27.
DOI: 10.1007/s10029-019-02074-9
Abstrakt: Background: Short-term success following robotic-assisted ventral hernia repair (RVHR) is well established; however, data describing outcomes after the first year are limited. In this study, we followed a cohort of patients with an average of 1.8 years of follow-up to demonstrate the durability of this technique and examine risk factors for recurrence.
Methods: A retrospective analysis of RVHR performed by a single surgeon from 2012 to 2016 was done. The technical approach for hernia repair consisted of tension-free primary fascial closure with placement of preperitoneal mesh when possible. The primary end point of hernia recurrence was determined based on physical examination or imaging documented in the medical record. A logistic regression model was used to identify patient risk factors for recurrence.
Results: One hundred and eight RVHRs were performed over 4 years. Mean age was 52.72 ± 13.61 years, BMI was 33.07 ± 7.82 kg/m 2 , and hernia defect size was 70.1 ± 86.3 cm 2 . In terms of patient characteristics, 17.6% of patients were diabetic, 13.9% were smokers preoperatively, 72.2% were ASA class 3 or higher, and 29.6% had prior VHR. Primary fascial closure was achieved in all RVHRs, with 23.1% requiring component separation. Mesh was used in 97.2% of patients: 79.5% had preperitoneal mesh and 17.6% had intraperitoneal onlay mesh. Ninety-eight percent of patients had long-term follow-up at a mean of 625.6 days. Recurrence rate was 12%, with one recurrence attributed to an inguinal hernia fixed concurrently with a midline defect. There were no statistically significant differences in gender, age, BMI, ASA class, incidence of diabetes, smoking status, or number of previous hernia repairs. Hernia defect size and perioperative complications including SSO, ileus, obstruction, or any other medical complication were not predictive of recurrence. Technical approach did not affect outcomes.
Conclusion: RVHR is safe and durable with a low recurrence rate at a mean of 21 months postoperatively. Patient characteristics or type of repair were not predictive of recurrence.
Databáze: MEDLINE